Companies /Consumer Defensive

Colgate-Palmolive Company

NYSE: CL Household & Personal Products
$90.10
▲ $0.47 (+0.52%) today
Markets closed · 3:34am ET

Q4 2025 Earnings

Reported Jan 30, 2026, 7:57am ET · SEC source
$0.95
Beat +4.18%
EPS · est. $0.91
$5.2B
Beat +2.13%
Revenue · est. $5.1B
+6.5%
Beating market
CL vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−2%0+2%+4%Jan 30Jan 30report 7:57am ETearnings−0.2%+4.7%
−2%0+2%+4%Jan 30Jan 30earnings−0.2%+4.7%
CL +4.7%S&P 500 −0.2%
−2%0+2%+4%Jan 30Jan 30report 7:57am ETearnings−1.0%+4.7%
−2%0+2%+4%Jan 30Jan 30earnings−1.0%+4.7%
CL +4.7%NASDAQ −1.0%
0+4%+8%Jan 29Feb 6report 7:57am ETearnings−0.1%+8.7%
0+4%+8%Jan 29Feb 6earnings−0.1%+8.7%
CL +8.7%S&P 500 −0.1%
−5%0+5%+10%Jan 29Feb 6report 7:57am ETearnings−2.8%+8.7%
−5%0+5%+10%Jan 29Feb 6earnings−2.8%+8.7%
CL +8.7%NASDAQ −2.8%
+5.92%
Day of report
+1.77%
Next session
+4.56%
One week
+5.53%
30 days

S&P 500 over the same 30 days: −0.99%.

Did CL Beat Earnings? Q4 2025 Results

Colgate-Palmolive delivered a stronger-than-expected fourth quarter, posting non-GAAP Base Business EPS of $0.95 against a consensus estimate of $0.91, a beat of 4.40%, while revenue of $5.23 billion topped the $5.13 billion estimate and rose 5.8% year over year. The headline results masked significant noise beneath the surface, as a $919 million pre-tax goodwill impairment charge tied to its Filorga skin health business, hurt by sluggish category growth and weakness in China, swung GAAP EPS to a loss of $0.05 per share. Operational resilience carried the non-GAAP story, with organic sales growth of 2.2% and a meaningful 3.1% tailwind from foreign exchange lifting reported sales. Africa/Eurasia led divisional performance at 10.3% organic growth, while North America slipped 1.8%. Looking ahead, management guided 2026 net sales growth of 2% to 6% and low-to-mid-single-digit Base Business EPS growth, while unveiling a new 2030 strategy centered on AI-driven analytics and science-based innovation. The company also extended its streak of consecutive annual dividend increases to 63 years, reinforcing its Dividend Aristocrat credentials.

Key Takeaways
  • Strength in oral care and pet nutrition categories drove organic sales growth
  • Pricing contributed 2.7% to Q4 sales growth while organic volume declined 0.5%
  • Foreign exchange provided a 3.1% positive impact on Q4 reported sales
  • Africa/Eurasia led regional organic sales growth at 10.3%, Latin America at 6.5%
  • North America organic sales declined 1.8%, the weakest performing region
  • Lower private label pet volume negatively impacted organic sales by 0.9% in Q4

“We are pleased to have exited 2025 with accelerated growth momentum on both the top and bottom lines, even in the face of sluggish category growth in many markets. Net sales and organic sales grew in every category during the quarter, led by strength in oral care and pet nutrition, excluding private label.”

Colgate-Palmolive CEO, on the earnings call

Forward Guidance & Outlook

For full year 2026, Colgate-Palmolive expects net sales growth of 2% to 6%, including a low-single-digit positive impact from foreign exchange. Organic sales growth is expected to be 1% to 4%, including an approximately 20 basis point impact from the exit of private label pet food. On a GAAP basis, the company expects gross profit margin expansion, advertising up on both a dollar basis and as a percentage of net sales, and double-digit EPS growth. On a non-GAAP Base Business basis, the company expects gross profit margin expansion, advertising increases, and low-to-mid-single-digit EPS growth. Guidance is based on current spot rates and includes the estimated impact of tariffs announced and finalized as of January 28, 2026.

CL YoY Financials

Q4 2025 vs Q4 2024 · SEC filings Q4 2024 Q4 2025
$0$2.0B$4.0B$4.9B$5.2BRevenue$3.0B$3.1BGross Profit$1.1B$92.0MOperating Income
$0$2.0B$4.0BRevenueGross ProfitOperating Income

CL Revenue by Segment

Oral, Personal and Home Care$4.0B+6.0%
Hill's Pet Nutrition$1.2B+4.9%

CL Revenue by Geography

Latin America$1.2B+12.8%
Europe$734.0M+9.8%
North America$1.0B−1.5%
Asia Pacific$722.0M−0.3%
Africa/Eurasia$309.0M+15.0%

Figures from SEC filings and company reports. Not investment advice.